* Verastem Inc reported a quarterly adjusted loss of $1.02 per share for the quarter ended in December, lower than the same quarter last year, when the company reported EPS of -96 cents. The mean expectation of eight analysts for the quarter was for a loss of 62 cents per share. Wall Street expected results to range from -88 cents to 43 cents per share.
* Reported revenue was zero; analysts expected $5.09 million.
* Verastem Inc's reported EPS for the quarter was a loss of $1.02.
* The company reported a quarterly loss of $27.37 million.
* Verastem Inc shares had risen by 31.9% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Verastem Inc is $32.00
This summary was machine generated from LSEG data March 14 at 09:42 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.62 -1.02 Missed
Sep. 30 2023 -0.84 -0.75 Beat
Jun. 30 2023 -1.06 -1.37 Missed
Mar. 31 2023 -0.98 -0.96 Beat
Comments